π’ Company
NeoGenomics
Cancer-focused genetic testing and lab services company
π Rating
1 news mentions Β· π 0 likes Β· π 0 dislikes
π Topics
- Financial Performance (1)
- Healthcare Industry (1)
- Market Analysis (1)
π·οΈ Keywords
NeoGenomics (1) Β· earnings report (1) Β· profitability (1) Β· genetic testing (1) Β· healthcare stocks (1) Β· quarterly results (1) Β· Wall Street analysis (1) Β· cost-cutting measures (1)
π Key Information
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.